EX-1.2
from S-1/A
7 pages
This Is to Confirm Our Agreement Whereby Cb Pharma Acquisition Corp., a Cayman Islands Exempted Company (“Company”), Has Requested Earlybirdcapital, Inc. (The “Advisor”) to Assist It in Connection With the Company Consummating a Merger, Share Exchange, Asset Acquisition, Share Purchase, Recapitalization, Reorganization or Other Similar Business Combination (In Each Case, a “Business Combination”) With One or More Businesses or Entities (Each a “Target”) as Described in the Company’s Registration Statement on Form S-1 (File No. 333-199558) Filed With the Securities and Exchange Commission (“Registration Statement”) in Connection With Its Initial Public Offering (“Ipo”). 1. Services and Fees. (A) if Requested by the Company, the Advisor Will: (I) Hold Meetings With Company Shareholders to Discuss the Business Combination and the Target’s Attributes; (II) Introduce the Company to Potential Investors to Purchase the Company’s Securities; (III) Assist the Company in Trying to Obtain Shareholder Approval for the Business Combination; and (III) Assist the Company With Any Press Releases and Filings Related to the Business Combination or the Target
12/34/56
